数据日期 2026-10-29 · 生成时间 2026-10-29 06:03
研究问题
Glutamate is the primary excitatory neurotransmitter in the central nervous system (CNS) that mediates excitatory synaptic transmission [1].
方法
Eight-week-old male C57BL/6 mice, weighing approximately 25–30 g, were employed in the in vivo experiments.；Animals were housed 2–3 per cage in the animal facility of the Institute of Molecular Biology and Biotechnology (IMBB)—Foundation for Research and Technology Hellas (FORTH) under stable conditions in a 12 h light–dark cycle and with food and water provided ad libitum.；All experimental procedures were performed by skilled individuals, holders of FELASA certificate, and were conducted, taking into consideration animal well-being and reduction in suffering, in accordance with the 3R principles, the EU directives (2010/63/EU and L 276/33/20.10.2010) and the Greek legislation (Presidential Decree 56/30.04.2013) for the care and use of laboratory animals.；For in vivo experiments, AM11920 was further diluted in NaCl 0.9% at a concentration of 0.5 mg/kg.
核心结论
结论：Collectively, the present study demonstrates that pharmacological enhancement of endogenous 2-AG signaling through inhibition of its primary hydrolyzing enzymes, MAGL and ABHD6, by AM11920, confers significant neuroprotection and exerts broad immunomodulatory control over excitotoxic inflammation induced by AMPA.
局限
Thus, the extent to which CB2R mediated the neuroprotective and anti-inflammatory actions of AM11920 remains to be established.；Another limitation of the present study is the dose of AMPA employed for the in vitro experiments (150 μΜ), which represents a robust excitotoxic challenge and may not directly reflect the concentration of glutamate, observed in vivo under excitotoxic conditions.；Apart from this, the lack of behavioral assessment represents another limitation of this study and therefore it remains unclear whether the protection observed at the cellular level translates into functional improvement too.
对本项目的价值
★★☆☆☆ 脑老化是最大未满足需求，也是终点最难量化的领域；biomarker 与认知读数选择最敏感。最大样本量约 3。
全文来源
PMC JATS 全文（正文 68,776 字符，已过标题/DOI 逐字归属校验）
原文题录
- 英文标题：Enhancement of Endocannabinoid Signaling by Dual MAGL/ABHD6 Inhibition Reduces Neurodegeneration and Neuro-Inflammation Following AMPA-Mediated Excitotoxicity.
- 期刊与标识：Biomolecules · PMID 42939750 · DOI 10.3390/biom16101496**
B 级证据分级：B 级（同行评议临床前研究，主要为动物模型）
本文核心结论来自动物模型或体外细胞学，属临床前证据，不能外推至人体。「延长健康寿命」「改善功能」等表述在小鼠中的意义，与人类临床结局之间仍有距离。
关于本文的文献来源：本站依据 IMA 知识库「五刊监控·深度文献卡片」撰写，依据已获取的期刊全文（方法、样本量与结论已回到原文核对）；未能获取全文的同批条目另行标注「摘要级」，全程未做任何数值推算补全。